Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 162

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 162
---
uting agents’ or underwriters’ compensation; |

| · | any public offering price; |

| · | any discounts or concessions allowed or reallowed or paid to dealers; and |

| · | any securities exchanges on which such securities may be listed. |

Agents

We may designate agents who agree to use their
reasonable efforts to solicit purchases for the period of their appointment or to sell the securities being offered hereby on a continuing
basis, unless otherwise provided in a prospectus supplement.

We may from time to time engage a broker-dealer
to act as our offering agent for one or more offerings of our securities. If we reach agreement with an offering agent with respect to
a specific offering, including the number of securities and any minimum price below which sales may not be made, then the offering agent
will try to sell such common stock on the agreed terms. The offering agent could make sales in privately negotiated transactions and/or
any other method permitted by law, including sales deemed to be an “at the market offering” as defined in Rule 415 promulgated
under the Securities Act, including sales made directly on the NYSE. The offering agent may be deemed to be an “underwriter”
within the meaning of the Securities Act, with respect to any sales effected through an “at the market offering.”

Underwriters

If we use underwriters for a sale of securities,
the underwriters will acquire the securities, and may resell the securities in one or more transactions, including negotiated transactions,
at a fixed public offering price or at varying prices determined at the time of sale. The obligations of the underwriters to purchase
the securities will be subject to the conditions set forth in the applicable underwriting agreement. We may change from time to time any
public offering price and any discounts or concessions the underwriters allow or reallow or pay to dealers. We may use underwriters with
whom we have a material relationship. We will describe in the prospectus supplement naming the underwriter the nature of any such relationship.

Institutional Purchasers

We may authorize underwriters, dealers or agents
to solicit certain institutional investors, approved by us, to purchase our securities on a delayed delivery basis or pursuant to delayed
delivery contracts provided for payment and delivery on a specified future date. These institutions may include commercial and savings
banks, insurance companies, pension funds, investment companies and educational and charitable institutions. We will describe in the prospectus
supplement details of any such arrangement, including the offering price and applicable sales commissions payable